Wall Street Analysts Predict a 45.04% Upside in Exact Sciences (EXAS): Here's What You Should Know

Group 1 - Exact Sciences (EXAS) shares have increased by 23.4% in the past four weeks, closing at $55.77, with a mean price target of$80.89 indicating a potential upside of 45% [1] - The mean estimate consists of 19 short-term price targets with a standard deviation of $9.28, suggesting a range of estimates from$66 (18.3% increase) to $100 (79.3% increase) [1] - Analysts show strong agreement on EXAS's earnings prospects, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [5] Group 2 - The Zacks Consensus Estimate for EXAS's current year earnings has increased by 12% over the last 30 days, with two estimates moving higher and one lower [5] - EXAS holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [5] - While price targets may not be reliable for predicting exact stock gains, they can indicate the direction of price movement, which is useful for investors [6]